Prognose
| Køb |
0 |
| Behold |
0 |
| Sælg |
1 |
Diskussioner i communityet
Der er endnu ingen diskussion om dette aktiv.
Start diskussionNyheder Til nyhedsfeedet
Spire Healthcare accepts takeover offer worth £1.03 billion
Spire Healthcare agreed to a takeover offer from a consortium that includes funds managed by Toscafund, Three Hills and Ares. Shareholders will receive 250 pence per share in cash, valuing the equity at around £1.03 billion. The stock then rose by more than 3% to 245.5 pence, reaching a one-year high. » Mere på de.investing.com
Takeover deadline for Spire Healthcare by Toscafund extended by one day
Toscafund has extended the deadline to submit a binding offer for Spire Healthcare to Friday at 17:00 London time in order to finalise financing documents. The potential cash offer amounts to 250 pence per share; due diligence is complete and the transaction documentation is nearly final. Toscafund may reduce the offer under certain conditions, and there is no certainty that a binding offer will actually be made. » Mere på de.investing.com
Spire Healthcare: takeover deadline for Toscafund extended by one day to 4 September
The board of Spire Healthcare said the deadline for a binding takeover offer from Toscafund Asset Management has been extended by one day to 4 September 2026. Toscafund announced a cash offer of 250 pence per share in May and confirmed that due diligence is complete, but still requires financing documentation and the final transaction documents. The offer remains subject to customary conditions, Toscafund reserves the right in certain circumstances to reduce the offer, and there is no certainty that a binding offer will actually be made. » Mere på de.investing.com
Spire Healthcare extends takeover deadline for offer from Toscafund to 21 August
Spire Healthcare said the deadline for a binding takeover offer from Toscafund has been extended to 21 August 2026. Toscafund has submitted a revised, non-binding offer of 250 pence per share in cash with an option for unlisted rollover shares and has largely completed its due diligence. The extension is intended to enable completion of the financing arrangements; a binding offer remains subject to usual conditions and is not certain. » Mere på de.investing.com
Debbie White to succeed Sir Ian Cheshire as chair of Spire Healthcare
Spire Healthcare said Sir Ian Cheshire will resign as chair on 30 September 2026. Debbie White, an independent non‑executive director since February 2023 and senior independent director since May 2023, will take on the role of designated chair with immediate effect and will assume the chair after Cheshire’s resignation. Sir Ian will be available in an advisory capacity during his six‑month notice period; Natalie Ceeney will take on the role of senior independent director. » Mere på de.investing.com
Historisk udbytte Udbytte
Alle nøgletal for udbytte Alle nøgletalI 2026 har Spire Healthcare Group allerede udloddet 0,0173 € i udbytte. Den seneste udlodning fandt sted i juni.
Virksomhedstal
I det seneste kvartal havde Spire Healthcare Group en omsætning på 920,17 mio. € og et nettoresultat på -13,7 mio. €
| (EUR) | juni 2026 | YoY |
|---|---|---|
| Omsætning | 920,17 mio. | - |
| Bruttofortjeneste | 343,83 mio. | - |
| Nettoresultat | -13,7 mio. | - |
| EBITDA | 130,71 mio. | - |
Fundamentale data
| Nøgletal | Værdi |
|---|---|
Markedsværdi | 1,19 mia. € |
Antal aktier | 400,6 mio. |
Højeste/laveste i 52 uger | 2,99 € - 1,68 € |
Udbytteafkast | 0,58 % |
Udbytte TTM | 0,0173 € |
Beta | 0,87 |
P/E (PE Ratio) | -526,60 |
PEG (PEG Ratio) | 4,78 |
K/I (PB Ratio) | 1,37 |
P/S (PS Ratio) | 0,63 |
Virksomhedsprofil
Spire Healthcare Group plc og dets datterselskaber ejer og driver private hospitaler og klinikker. Virksomheden tilbyder forskellige behandlinger inden for allergi og infektionssygdomme, blodprøver, knogler og led, tarmbehandlinger, brystscreening, kræftundersøgelser og -behandlinger, kosmetisk kirurgi, fjernelse af cyster og tandkirurgi samt øre-, næse- og halsbehandlinger. Selskabet tilbyder også øjenkirurgi og -behandlinger, familieplanlægning, gastroenterologi, almen medicin, almen kirurgi, hæmatologi, håndkirurgi, behandling af hofte og knæ samt hjerte- og nyrebehandlinger. Derudover tilbyder det behandlinger inden for mænds sundhed, neurokirurgi og neurologi, pædiatri, smertebehandling, rehabilitering, sport, fysioterapi, fodterapi, respiratorisk behandling og reumatologi; samt scanninger og undersøgelser, hudbehandlinger, rygbehandling, sportsvidenskab, urologisk behandling, karkirurgi, vægttab og kvindesundhed. Endvidere tilbyder virksomheden forskellige test og scanninger, herunder hjerte-CT, CT, MR, ultralyd og røntgenscanninger. Den tilbyder diagnostik, indlagt pleje, dagkirurgi og ambulant pleje gennem 40 hospitaler og otte klinikker i England, Wales og Skotland. Spire Healthcare Group plc blev grundlagt i 2007 og har hovedkontor i London, Storbritannien.
| Navn | Spire Healthcare Group |
| CEO | Justin Ash |
| Hjemsted | London,
gl Storbritannien |
| Websted | |
| Børsnotering | 18.07.2014 |
| Medarbejdere | 17.800 |
Tickersymboler
| Børs | Symbol |
|---|---|
London Stock Exchange | SPI.L |
Frankfurt | S00.F |
Düsseldorf | S00.DU |
London | SPI.L |
München | S00.MU |